AAAAAA

   
Results: 1-22 |
Results: 22

Authors: KAIREMO KJA JEKUNEN AP KORPPITOMMOLA ET PYRHONEN SO
Citation: Kja. Kairemo et al., THE EFFECT OF LITHIUM GAMMA-LINOLENATE THERAPY OF PANCREATIC-CANCER ON PERFUSION IN LIVER AND PANCREATIC TISSUES, Pancreas, 16(1), 1998, pp. 105-106

Authors: JEKUNEN AP KAIREMO KJA PAAVONEN T
Citation: Ap. Jekunen et al., IMAGING OF HAND-SCHULLER-CHRISTIAN-SYNDROME BY A MONOCLONAL-ANTIBODY, Clinical nuclear medicine, 22(11), 1997, pp. 771-774

Authors: KAIREMO KJA RAMSAY HA TAGESSON M JEKUNEN AP PAAVONEN TK JAASKELASAARI HA LIEWENDAHL K LJUNGGREN K SAVOLAINEN S STRAND SE
Citation: Kja. Kairemo et al., IN-111 BLEOMYCIN COMPLEX FOR RADIOCHEMOTHERAPY OF HEAD AND NECK-CANCER - DOSIMETRIC AND BIOKINETIC ASPECTS (VOL 23, PG 631, 1996), European journal of nuclear medicine, 24(2), 1997, pp. 235-235

Authors: JEKUNEN AP KAIREMO KJA
Citation: Ap. Jekunen et Kja. Kairemo, INHIBITION OF MALIGNANT ANGIOGENESIS, Cancer treatment reviews, 23(4), 1997, pp. 263-286

Authors: KAIREMO KJA JEKUNEN AP KORPPITOMMOLA ET PYRHONEN SO
Citation: Kja. Kairemo et al., EFFECTS OF LITHIUM GAMMALINOLENATE ON THE PERFUSION OF LIVER AND PANCREATIC TISSUES IN PANCREATIC-CANCER, Anticancer research, 17(5B), 1997, pp. 3729-3736

Authors: VLAYKOVA T JEKUNEN AP KESOMAA M KAIREMO KJA PYRHONEN S WASENIUS VM
Citation: T. Vlaykova et al., INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA, Oncology, 54(2), 1997, pp. 146-152

Authors: LAITINEN JO KAIREMO KJA JEKUNEN AP KORPPITOMMOLA T TENHUNEN M
Citation: Jo. Laitinen et al., THE EFFECT OF 3-DIMENSIONAL ACTIVITY DISTRIBUTION ON THE DOSE PLANNING OF RADIOIMMUNOTHERAPY FOR PATIENTS WITH ADVANCED INTRAPERITONEAL PSEUDOMYXOMA, Cancer, 80(12), 1997, pp. 2545-2552

Authors: KAIREMO KJA TENHUNEN M JEKUNEN AP
Citation: Kja. Kairemo et al., DOSIMETRY OF RADIONUCLIDE THERAPY USING RADIOPHOSPHONATED ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES BASED ON ANIMAL PHARMACOKINETIC AND TISSUE DISTRIBUTION DATA, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 6(3), 1996, pp. 215-220

Authors: KAIREMO KJA JEKUNEN AP BONDESTAM S KORPPITOMMOLA ET SAVOLAINEN S PAAVONEN T
Citation: Kja. Kairemo et al., DETECTION OF PSEUDOMYXOMA PERITONEI BY RADIOIMMUNOHISTOCHEMISTRY AND RADIOIMMUNOSCINTIGRAPHY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 325-334

Authors: JEKUNEN AP KAIREMO KJA RAMSAY HA KAJANTI MJ
Citation: Ap. Jekunen et al., IMAGING OF OLFACTORY NEUROBLASTOMA BY IN-111 BLEOMYCIN COMPLEX, Clinical nuclear medicine, 21(2), 1996, pp. 129-131

Authors: JAASKELASAARI HA KAIREMO KJA JEKUNEN AP PEKKOLAHEINO K KULMALA J RAMSAY HA GRENMAN R
Citation: Ha. Jaaskelasaari et al., CYTOTOXICITY OF BLEOMYCIN AND EXTERNAL RADIATION IN SQUAMOUS-CELL CANCER CELL-LINES OF HEAD AND NECK, Cancer detection and prevention, 20(4), 1996, pp. 279-284

Authors: KAIREMO KJA RAMSAY HA TAGESSON M JEKUNEN AP PAAVONEN TK JAASKELASAARI HA LIEWENDAHL K LJUNGGREN K SAVOLAINEN S STRAND SE
Citation: Kja. Kairemo et al., IN-111 BLEOMYCIN COMPLEX FOR RADIOCHEMOTHERAPY OF HEAD AND NECK-CANCER - DOSIMETRIC AND BIOKINETIC ASPECTS, European journal of nuclear medicine, 23(6), 1996, pp. 631-638

Authors: KORPPITOMMOLA ET KAIREMO KJA JEKUNEN AP NISKANEN EO SAVOLAINEN SE
Citation: Et. Korppitommola et al., DOUBLE-TRACER DOSIMETRY OF ORGANS IN ASSESSMENT OF BONE-MARROW INVOLVEMENT BY 2 MONOCLONAL-ANTIBODIES, Acta oncologica, 35(3), 1996, pp. 357-365

Authors: JEKUNEN AP KAIREMO KJA LEHTONEN HP KAJANTI MJ
Citation: Ap. Jekunen et al., TREATMENT OF OLFACTORY NEUROBLASTOMA - A REPORT OF 11 CASES, American journal of clinical oncology, 19(4), 1996, pp. 375-378

Authors: KAIREMO KJA TENHUNEN M JEKUNEN AP
Citation: Kja. Kairemo et al., OLIGORADIONUCLIDETHERAPY USING RADIOLABELED ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES, Anti-cancer drug design, 11(6), 1996, pp. 439-449

Authors: KAIREMO KJA KARNANI P JEKUNEN AP
Citation: Kja. Kairemo et al., MODULATION OF ANTIBODY KINETICS BY THE CELL-MEMBRANE ACTIVE AGENT TWEEN-80 IN-VIVO, Anticancer research, 16(6B), 1996, pp. 3542-3550

Authors: RAMSAY HA KAIREMO KJA JEKUNEN AP
Citation: Ha. Ramsay et al., SOMATOSTATIN RECEPTOR IMAGING OF OLFACTORY NEUROBLASTOMA, Journal of Laryngology and Otology, 110(12), 1996, pp. 1161-1163

Authors: CHRISTEN RD ISONISHI S JONES JA JEKUNEN AP HOM DK KRONING R GATELY DP THIEBAUT FB LOS G HOWELL SB
Citation: Rd. Christen et al., SIGNALING AND DRUG-SENSITIVITY, Cancer metastasis reviews, 13(2), 1994, pp. 175-189

Authors: JEKUNEN AP HOM DK ALCARAZ JE EASTMAN A HOWELL SB
Citation: Ap. Jekunen et al., CELLULAR PHARMACOLOGY OF DICHLORO(ETHYLENEDIAMINE) PLATINUM(II) IN CISPLATIN-SENSITIVE AND RESISTANT HUMAN OVARIAN-CARCINOMA CELLS, Cancer research, 54(10), 1994, pp. 2680-2687

Authors: JEKUNEN AP CHRISTEN RD SHALINSKY DR HOWELL SB
Citation: Ap. Jekunen et al., SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND TAXOL IN HUMAN OVARIAN-CARCINOMA CELLS IN-VITRO, British Journal of Cancer, 69(2), 1994, pp. 299-306

Authors: CHRISTEN RD JEKUNEN AP JONES JA THIEBAUT F SHALINSKY DR HOWELL SB
Citation: Rd. Christen et al., IN-VITRO MODULATION OF CISPLATIN ACCUMULATION IN HUMAN OVARIAN-CARCINOMA CELLS BY PHARMACOLOGICAL ALTERATION OF MICROTUBULES, The Journal of clinical investigation, 92(1), 1993, pp. 431-440

Authors: JEKUNEN AP SHALINSKY DR HOM DK ALBRIGHT KD HEATH D HOWELL SB
Citation: Ap. Jekunen et al., MODULATION OF CISPLATIN CYTOTOXICITY BY PERMEABILIZATION OF THE PLASMA-MEMBRANE BY DIGITONIN INVITRO, Biochemical pharmacology, 45(10), 1993, pp. 2079-2085
Risultati: 1-22 |